Shweta Joshi

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Peritoneal Dialysis

Patient Reported Outcomes

Chemotherapy Induced

Chronic Lymphocytic Leukemia

Top Venues

Cancer research

Journal of oncology

University of California San Diego

Central Drug Research Institute (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California San Diego Dec 01 2019

United States

Assistant Professor :: Pediatrics

University of California San Diego Dec 14 2014

United States

Assistant Project Scientist :: pediatrics

University of California San Diego Dec 14 2009 - Dec 14 2015

United States

Postdoctoral fellow :: Pediatrics

Education History

Central Drug Research Institute Oct 25 2004 - Nov 11 2009

India

PHD :: Biochemistry

Publications

Deepak Rohila, In Hwan Park, Timothy V Pham, Jonathan R Weitz, Tatiana Hurtado de Mendoza, Suresh Madheswaran, Mehreen Ishfaq, Cooper Beaman, Elisabette Tapia, Siming Sun, Jay Patel, Pablo Tamayo, Andrew M Lowy, Shweta Joshi
Syk inhibition reprograms tumor-associated macrophages and overcomes gemcitabine-induced immunosuppression in pancreatic ductal adenocarcinoma. Cancer research (2023)
Mehreen Ishfaq, Timothy Pham, Cooper Beaman, Pablo Tamayo, Alice L Yu, Shweta Joshi
BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma. Cancers 13 (4) (2021)
Shweta Joshi, Donald L Durden
Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System. Journal of oncology 2019 (2019)